Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?

By Eichler Hans-Georg   Kong Sheldon   Grégoire Jean-Pierre  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-06 ,pp. : 129-136

Springer Publishing Company

Access to resources Recommend Favorite

Third-party disability in family members of people with aphasia: a systematic review

By Grawburg Meghann  

Disability and Rehabilitation, Vol. 35, Iss. 16, 2013-08 ,pp. : 1324-1341

Informa Healthcare

Access to resources Recommend Favorite

A paired comparison analysis of third-party rater thyroidectomy scar preference

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 1, 2017-01 ,pp. : 13-18

Cambridge University Press

Access to resources Recommend Favorite

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US*

By Charles Meaghan St.   Minshall Michael E.   Pandya Bhavik J.   Baran Robert W.   Tunis Sandra L.  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1343-1353

Informa Healthcare

Access to resources Recommend Favorite

Third-party payer response to requests for purchase of communication augmentation systems: a study of Washington state

By Beukelman David   Yorkston Kathryn   Smith Kathleen  

Augmentative & Alternative Communication, Vol. 1, Iss. 1, 1985-01 ,pp. : 5-9

Informa Healthcare

Access to resources Recommend Favorite